Although initially considered as a potential oncogene due to its ability to drive S-phase progression in quiescent cells (162, 163), data obtained in E2F1-null mice (82, 83) revealed a potential tumor suppressor role associated with impaired apoptosis induction (82, 83). Here, E2F1 is linked to neoplasm.